Clinical TrialID 6851

Bioefficacy of Beta-cryptoxanthin From Biofortified Maize

NCT04153968

Vitamin A Deficiency

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
6851
Evidence Id
6851
Core Evidence Id
6851
Source Clinical Trial Id
6842
Herb2 Clinical Trial Id
HBCT006842
Nct Id
NCT04153968
Title
Bioefficacy of Beta-cryptoxanthin From Biofortified Maize
Status
Phase
Study Result
No
Study Condition
Vitamin A Deficiency
Study Type
Interventional
Study Design
Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Intervention
DIETARY_SUPPLEMENT: β-cryptoxanthin
Intervention Allocation
Non_Randomized
Intervention Model
Sequential
Intervention Mask
Intervention Purpose
Basic_Science
Gender
All
Age
Adult
Enrollment
50
Outcome Measure
Bioefficacy of β-cryptoxanthin, Plasma concentrations of \[13C14\]-β-cryptoxanthin, \[13C7\]-retinyl esters, and \[13C7\]-retinol., Phase 1 = 91 days. Phase 2 = 22 days.
Sponsor Collaborator
Newcastle University|International Food Policy Research Institute|Penn State University
Funded By
OTHER
Location
Newcastle University, Newcastle Upon Tyne, Tyne & Wear, NE2 4HH, United Kingdom
Other Id
BH183438
Start Date
2019-04-01
Primary Completion Date
2020-12-31
Completion Date
2020-12-31
First Posted
2019-11-06
Results First Posted
Last Update Posted
2020-11-04
Study Document
Study Url
https://clinicaltrials.gov/study/NCT04153968
Title Cn
Title En
Bioefficacy of Beta-cryptoxanthin From Biofortified Maize
Bilingual Status
semi_complete